 The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics PK of 2 different TR-701 oral formulations free acid phosphate powder in capsule and di-sodium phosphate salt formulated capsule after single doses in normal healthy adult subjects and to assess the relative bioavailability of TR-701 free acid phosphate powder in capsule formulation compared to di-sodium phosphate salt formulated capsule. 